AZ to appeal NICE rejection for lung cancer drug

8th July 2019 Uncategorised 0

The committee didn’t OK the drug as the cost effectiveness estimates were above what NICE normally considers to be an acceptable use of NHS resources.

More: AZ to appeal NICE rejection for lung cancer drug
Source: News